Same-day discharge after holmium laser enucleation facilitated by medical support teams

Published On 2022-01-24 03:30 GMT   |   Update On 2022-01-24 03:30 GMT

Adequate support of healthcare teams alleviates barriers to successful same-day discharge pathway for Holmium Laser Enucleation of the Prostate pathway, according to a recent study published in the Urology. A group of researchers conducted a study to investigate perceived barriers to successful same-day discharge (SDD) after holmium laser enucleation of the prostate (HoLEP) from...

Login or Register to read the full article

Adequate support of healthcare teams alleviates barriers to successful same-day discharge pathway for Holmium Laser Enucleation of the Prostate pathway, according to a recent study published in the Urology.

A group of researchers conducted a study to investigate perceived barriers to successful same-day discharge (SDD) after holmium laser enucleation of the prostate (HoLEP) from the perspective of surgical and nursing staff members.

A 17-question survey was administered to intraoperative and postoperative surgical staff in June 2021 after a six-month period of implementing an SDD holmium laser enucleation of the prostate (HoLEP) pathway with same-day catheter removal. McNemar's and Stuart-Maxwell tests were performed for statistical analysis.

Results of the study are:

Surveys were completed by 30 respondents. The majority of respondents had less than 5 years of surgical experience (63%). Almost all respondents (96%) felt that holmium laser enucleation of the prostate (HoLEP) patients could be discharged safely on the day of surgery. Overall, 60% felt that holmium laser enucleation of the prostate (HoLEP) had a lower risk of postoperative bleeding compared to other transurethral surgeries. There was a significant decrease in the number of respondents that felt apprehensive when comparing initiation of SDD HoLEP pathway to 6-months post-implementation (43% vs 7%, p=0.003). The most common factors causing apprehension both pre-and post-implementation included: degree of hematuria (43% vs 40%, p=0.56), risk of failure of trial of void (40% vs 30%, p=0.26), and risk of readmission or unplanned emergency department (ED) visit (33% vs 30%, p=0.48). There was a significant decrease in the number of respondents who were apprehensive about lack of experience with SDD after HoLEP comparing pre-and post-implementation (20% vs 0%, p=0.01).

Thus, the researchers concluded that while staff report initial apprehension regarding implementation of an SDD HoLEP pathway, adequate support to intraoperative and postoperative teams helps build an experience that alleviates these concerns.

Reference:

Barriers to implementation of a same-day discharge pathway for Holmium Laser Enucleation of the Prostate by Jenny Guo, et al. published in the Urology.

https://www.goldjournal.net/article/S0090-4295(21)01184-5/fulltext


Tags:    
Advertisement
Article Source : Urology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News